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Background: In Zambia, there has been a large scaling up of interventions to control malaria in recent years
including the deployment of rapid diagnostic tests (RDTs) to improve malaria surveillance data as well as guide
malaria treatment in health facilities. The practical challenge is the impact of RDT results on subsequent
management of patients. This study explored the role of RDTs in malaria diagnosis and the health workers’
adherence to test results.
Methods: An observational prospective study was carried out at health centres in four districts, namely Chibombo,
Chingola, Chipata, and Choma. Children under the age of five years with history of fever were recruited and the
clinicians’ use of RDT results was observed to establish whether prescriptions were issued prior to the availability
of parasitological results or after, and whether RDT results influenced their prescriptions.
Results: Of the 2, 393 recruited children, 2, 264 had both RDT and microscopic results. Two in three (68.6%)
children were treated with anti-malarials despite negative RDT results and almost half (46.2%) of these were
prescribed Coartem®. Only 465 (19.4%) of the 2,393 children were prescribed drugs before receiving laboratory
results. A total of 76.5% children were prescribed drugs after laboratory results. Children with RDT positive results
were 2.66 (95% CI (2.00, 3.55)) times more likely to be prescribed anti-malarial drugs. Children who presented with
fever at admission (although history of fever or presence of fever at admission was an entry criterion) were 42%
less likely to be prescribed an anti-malarial drug compared to children who had no fever (AOR = 0.58; 95% CI
(0.52, 0.65)). It was noted that proportions of children who were RDT- and microscopy-positive significantly declined
over the years from 2005 to 2008.
Conclusions: RDTs may contribute to treatment of febrile illness by confirming malaria cases from non-malaria
cases in children under the age of five. However, the adherence of the health workers to prescribing anti-malarials
to only RDT-positive cases at health facility level will still require to be explored further as their role is crucial in
more precise reporting of malaria cases in this era towards malaria elimination as the target.
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The current global policy recommendation is universal
access to parasite-based diagnosis of malaria-like febrile
illness [1] due to the use of artemisinin-based combin-
ation therapy (ACT), as the first-line anti-malaria treat-
ment for Plasmodium falciparum infection in most
endemic countries. ACT is expensive and relies on an
insecure supply of raw materials. It is also documented
that non-malarial febrile illnesses exert higher childhood
mortality across malaria-endemic countries than malaria
[2]. It is for this reason that rapid diagnostic tests
(RDTs) have an important role to play in targeting treat-
ment with ACT to malaria cases, and non-malarial cases
to other forms of management.
Malaria continues to be a disease of public health im-
portance in Zambia. There has been a large scaling up
of interventions to control malaria in recent years [3]. In
2009, 2.9 million cases and about 3,862 malaria attribut-
able deaths were reported in a population of 12 million,
down from 3.3 million reported cases and 9,369 deaths
[4]. This is because, in 2004, Zambia began to progres-
sively introduce ACT in response to growing and wide-
spread resistance to sulphadoxine-pyrimethamine (SP)
and chloroquine (CQ) with full national scale reached by
early 2005 [5]. At the time of the shift to ACT much diag-
nosis was based on non-specific symptoms rather than
confirmed malaria parasitaemia; consequently, actual mal-
aria incidence at health facilities remained unquantified
and many anti-malarial treatments were misdirected [5].
Zambia was faced with poor malaria surveillance data
caused by inadequate laboratory diagnostic facilities in
most parts of the country at the time of introduction of
ACT. This, coupled with substantial higher cost of
Coartem® compared with SP and CQ, compelled the
National Malaria Control Programme (NMCP) to intro-
duce RDTs, firstly as pilot in some districts in 2005 and
2006. Scale up at national level was achieved in 2009, when
Zambia made the transition to a strategy of full reporting
and treatment using only parasitologically confirmed
diagnosis nationwide [5]. Laboratory diagnosis is now
mandatory, where capacity exists, before anti-malarial
treatment, although in some cases stock outs of reagents
or test kits may prevent full enactment of this policy [6].
The practical challenge is that the impact of RDT re-
sults on subsequent management of patients varies. The
impact of RDTs on anti-malaria consumption has been
demonstrated widely [5,7,8] but a number of field trials
have also demonstrated poor adherence to results, there-
fore reducing the potential of RDTs to improve disease
management [9-12]. RDT uptake and utilization remains
low in public health settings; evidence shows that pro-
viding RDTs in the context of formal health care settings
may have limited impact on clinicians’ prescribing
behaviour [13,14], yet the cost benefits of improveddiagnosis can only be realized when treatment is consist-
ent with test results [15]. Most of the data available on
the usefulness of RDTs in many settings has been gener-
ated in research settings with limited consideration of
their impact on anti-malarial drug consumption in real-
life settings [16]. It is hoped that RDTs may contribute
to changing malaria reporting practices and the usage of
ACT in Zambia and that over time RDTs can change
clinical practice and move the case definition of malaria
(meaning all suspected malaria cases or all fever cases)
in routine health systems to a definition of malaria that
is routinely based on laboratory-confirmed parasitaemia
combined with clinical symptoms [5].
A study was conducted to explore the role of RDTs in
order to determine the adherence (i.e. the compliance to
treat every patient with positive RDT result with an anti-
malarial and not to treat when the RDT is negative) by
health workers to test results for the management of fe-
brile illness in children under five years of age in four
districts of different epidemiological zones. The study
was designed to compare the extent of excessive use of
Coartem® between the clinical paradigm and the RDT
with the standard thick blood film microscopy.
Methods
Study area
The study was conducted from 2005 to 2008 in four dis-
tricts, namely Chingola, Chibombo, Choma, and Chipata
which cover a range of transmission intensity. In each one
of these districts, two health facilities were selected. In
Chingola, the study was conducted at Chawama clinic and
Clinic 1; in Chibombo, at Liteta Hospital and Chisamba
clinic. In Choma, the study was conducted at Shampande
clinic and Choma General Hospital and in Chipata at
Kapata Clinic and Chipata Health Affiliated Clinic (HAC).
At the time of the conduct of the study, Chingola, in
the Copperbelt province of Zambia with a population of
177,445 (2000 Census), was a district in an area of high
malaria transmission with prevalence in the range of
35% in the dry season between May and October and
70% in the wet season, November to April, in children
under the age of five years attending outpatient care.
Choma with a population of 203,305 (2000 Census) in
the Southern Province of Zambia, on the other hand,
was in an area of unstable but severe and irregular trans-
mission. The prevalence of malaria in children under
five years of age ranged between 33 and 68%. Chipata
situated in the Eastern Province of Zambia with a popu-
lation of 362,132 (2000 Census) was in an area of stable
transmission with prevalence rates ranging from 35 to
70%. Chibombo with a population of 242,380 (2000
Census) in the central part of the country was in a
medium transmission zone with prevalence ranging
from 5 to 45%.
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The study population was children under the age of five
years, weighing more than 10 kg and residing within the
catchment area of the recruiting health facility. These chil-
dren were included in the study based on history (or pres-
ence) of fever and being clinically diagnosed as having
malaria by the attending clinician at the health facility.Study procedure
The study clinician examined each child who was eli-
gible to enter the study, took history and explained the
study protocol to the parent or guardian of the child.
Written consent was obtained from all parents or guard-
ians who agreed to have their children participate in the
study. Two scenarios were observed and noted by study
investigators. The clinician, at his/her own discretion,
prescribed an anti-malarial before the patient went to
the laboratory for an RDT or at the clinician’s discretion,
the patient was sent to the laboratory for a malaria test
and anti-malarial prescription was given only after RDT
results were made available. The study investigators
(blinded to the clinician) took note of the adherence of
the attending clinician to await a RDT result before pre-
scribing an anti-malarial or prescribing of the anti-
malarial before the availability of the RDT results.
All patients were advised to return for review on day 3
and 7. On these days, only blood for microscopy was
collected to ensure the patients were fully treated and
recovered before being discharged from the sick list.
In the laboratory, a finger prick was made on the
patient to collect blood for RDT (ICT Malaria Combo
Cassette Test Ref: ML02 25 Test Kit from ICT Diagnos-
tics, Bedfordview, 2008, South Africa) and microscopy.
Only the RDT result was available to the clinician (for
those patients whom prescription awaited laboratory re-
sults). Blood slides were stained and read later within
the health facilities and results entered in the log books.Training
Consistency of operation was required for the study to
be conducted in a uniform manner across the country;
therefore an element of training study staff was crucial
before the study was initiated. This was carried out at a
neutral venue, under the coordination of the investiga-
tors. The training took seven days and the following
comprised the content of the training: to administer the
study information and informed consent form; to fill out
details on a structured case record form (CRF); how to
follow step-by-step the patient flow chart and the aspect
of counselling the patient about post-treatment follow-
up. The latter included what the parent/guardian should
do in the event that the child’s condition post-consultation
with study staff worsened; information regarding whattreatment the child had been prescribed and counselling
for the third and seventh day follow-up visits.
Data management and analysis
The data were entered and initially analysed in EPI
INFO (version 3.3.2 of 2005). Consistency and range
checks were used to edit the data. Further analysis was
conducted using SPSS (version 17.0 of 2008). The
Cohen’s Kappa statistic with its 95% confidence interval
was used to measure the extent of agreement between
RDT and microscopic results. Multivariate logistic re-
gression analysis was conducted to determine independ-
ent factors associated with the outcome. Adjusted odds
ratios (AORs) and their 95% CIs were reported.
Variables
The variables used for analysis included the following:
fever (axillary temperature of 37.4 degrees Celsius or
higher), history of fever, laboratory result by RDT, anti-
malarial drugs prescribed (Coartem®, SP or quinine),
prescription given (before or after).
Ethical considerations
The study was conducted after approval from the Trop-
ical Diseases Research Centre (TDRC) Ethics Review
Committee. Technical support throughout the proposal
development and planning phase came from MIM/
WHO/TDR.
Results
A total of 2,393 children participated in the study
of which 52.1% were males. The median age was 25
(Q1 = 17, Q3 = 36) months. Altogether 2,264 children
had both the RDT and microscopic results: 640 were
from Chibombo, 584 from Chingola, 398 from Chipata
and 642 from Choma.
Overall, 68.6% of the children were treated for malaria
despite having negative RDT results. There were a total
44.9% of the children from Chibombo, 69.5% from
Chingola, 97.0% from Chipata, and 57.2% from Choma
(Table 1). Almost half (46.2%) of the children across all
districts who were negative on RDT results were given
Coartem®.
As investigators observed the prescribers (in a blinded
manner) and noted those who prescribed anti-malarials
prior to the availability of laboratory results, it was ob-
served that overall, 465 (19.4%) out of 2,393 children
were prescribed anti-malarial drugs before receiving
laboratory results. Of the children who received anti-
malarial prescription before receiving laboratory results,
84.0% were later found to be RDT result negative; 77.8%
had no fever; 54.0% received Coartem® while 36.1% re-
ceived SP, 5.4% quinine and 4.5% did not receive any
anti-malarial drug (Table 2).
Table 1 Treatment given regardless of rapid diagnostic test results
RDT results
District/ Positive Negative Total
Treatment given n (%) n (%) n (%)
Chibombo Total = 47 (16.1) Total = 245 (83.9) Total = 292 (100)
Coartem® 36 (76.6) 85 (34.7) 121 (41.4)
SP 5 (10.6) 25 (10.2) 30 (10.3)
Quinine 1 (2.1) 2 (0.8) 3 (0.01)
None 5 (10.6) 133 (54.3) 138 (47.3)
Chingola Total = 71 (13.1) Total = 470 (86.9) Total = 541 (100)
Coartem® 54 (76.1) 214 (45.5) 268 (49.5)
SP 7 (9.9) 104 (22.1) 111 (20.5)
Quinine 5 (7.0) 9 (1.9) 14 (2.6)
None 5 (7.0) 143 (30.4) 148 (27.4)
Chipata Total = 39 (11.6) Total = 296 (88.4) Total = 335 (100)
Coartem® 22 (56.4) 205 (69.3) 227 (67.8)
SP 5 (12.8) 73 (24.7) 78 (23.3)
Quinine 10 (25.6) 9 (3.0) 19 (5.7)
None 2 (5.1) 9 (3.0) 11 (3.3)
Choma 41 (12.6) 283 (87.3) 324 (100)
Coartem® 32 (78.0) 94 (33.2) 126 (38.9)
SP 6 (14.6) 68 (24.0) 74 (22.8)
Quinine 3 (7.3) 0 (0) 3 (1.0)
None 0 (0) 121(42.8) 121 (37.3)
All districts Total = 198 (13.3) Total = 1,294 (86.7) Total = 1,492 (100)
Coartem® 144 (72.7) 598 (46.2) 742 (49.7)
SP 23 (11.6) 270 (20.9) 293 (19.6)
Quinine 19 (9.6) 20 (1.5) 39 (2.6)
None 12 (6.1) 406 (31.4) 418 (28.0)
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who were prescribed anti-malarials before receiving
laboratory results by district. About half (53.6%) of
the children from Chibombo received anti-malarial pre-
scriptions before receiving laboratory results, while in
Chipata 0.9% of the children were prescribed anti-
malarials before receiving laboratory results.
A total of 1,498 (76.5%) of the 1,958 children were given
anti-malarial prescriptions after receiving laboratory results
(Table 4). No information was recorded on six children.
While children who had only fever or had fever with RDT
negative result were less likely to receive a prescription,
children who had RDT positive result, had fever and had
RDT positive result, had no fever and had RDT positive re-
sult, were more likely to receive anti-malarial prescription.
On multivariate analysis, RDT results and fever were sig-
nificantly associated with prescribing anti-malarial drugs
after knowing laboratory results (Table 5). Children who
had RDT result positive were 2.66 (95% CI (2.00, 3.55))times more likely to be prescribed anti-malarial drugs than
children who were RDT result negative. Meanwhile, chil-
dren who presented with fever at admission were 42%
(AOR= 0.58; 95% CI (0.52, 0.65)) less likely to be prescribed
anti-malarial drugs compared to children who had no fever
(although of course had history of fever at presentation).
Changes in microscopic and RDT results as well as
proportions being prescribed anti-malarials for positive
laboratory results over time are shown in Figure 1. In all
the three parameters, proportions of children who were
positive and prescribed anti-malarials significantly declined
over time (microscopic results: slope =−7.590, 95% CI:
−8.615, −6.565; RDT results: slope = −7.440, 95% CI:
−10.968, −3.912; prescribed anti-malarials: slope = −12.130,
95% CI: −21.391, −2.869).
Discussion
The World Health Organization (WHO) recommends
confirmatory diagnosis before treatment in all settings
Table 2 Distributions of fever, anti-malarial drugs given
and rapid diagnostic test results by anti-malarial drug
prescription after laboratory results
Factor Anti-malarial drug prescribed after laboratory result
Yes No
n (%) n (%)
Fever
Yes 888(59.3) 103 (22.2)
No 610 (40.7) 360 (77.8)
Total 1,498 (100) 463 (100)
Anti-malarial drug given
Coartem® 743 (49.6) 251 (54.0)
SP 296 (19.7) 168 (36.1)
Quinine 41 (2.7) 25 (5.4)
None 419 (28.0) 21 (4.5)
Total 1,499 (100) 465 (100)
RDT result
Positive 200 (13.4) 74 (16.0)
Negative 1,295 (86.6) 389 (84.0)
Total 1,495 (100) 463 (100)
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Ministry of Health in Zambia revised the national guide-
lines in 2009–2010 to mandate parasitological confirm-
ation of malaria based on microscopy or RDTs in the
public and private sectors, with RDTs to be used where
microscopy was not available, or where RDT use on an
outpatient basis by non-laboratory staff would reduce la-
boratory workloads [17].
This study was carried out before the guidelines were
enforced and the assessment of the prescribing practices
between availability of laboratory results and anti-malarial
prescriptions indicated that only 19.4% of children were
prescribed medication prior to receiving laboratory results.
This category of clinicians did not wait for the availability
of results before prescribing anti-malarials. However, for
this smaller number, over 50% of the prescriptions given
(i.e. 9.7% of the children) were Coartem® and lesser of
other anti-malarials. Over 77.8% of these patients wereTable 3 Proportions of children prescribed anti-malarials aga
District Total (%) Prescrib
Yes
n (%)
Chibombo 647 (100) 347 (53.6
Chingola 606 (100) 32 (5.3)
Chipata 461 (100) 4 (0.9)
Choma 679 (100) 83 (12.2)
Total 466not febrile. On counterchecking the parasitological results
of the patients who received anti-malarials prior to labora-
tory results, 84.0% were RDT-negative who should not
otherwise have received anti-malarial medication. One as-
sumption that could be made is that this category of
health workers (who prescribed for the 19.4% patients)
may perhaps not trust the laboratory results yet, or that
they remain with the orientation of prescribing an anti-
malarial under the Integrated Management of Childhood
Illness (IMCI) guidelines (although the absence of fever
in most cases contradicts this). Chibombo district was
most affected by prescriber preference to treat with an
anti-malarial before the laboratory results (53.6%). It’s
encouraging however, to generally note that the number
of children in this study who were treated before labora-
tory results were fewer.
Of the children whose laboratory results were available
before prescriptions were given, those whose results
were RDT-positive were 2.66 times more likely to re-
ceive an anti-malarial. Nonetheless, for the children who
had fever (who presented at the health facility with
raised temperature), they were 42% less likely to be pre-
scribed anti-malarial drugs compared to their counter-
parts who had no fever. This should be interpreted
with caution as all children recruited in this study
had either a history of fever or were found to be fe-
brile at the time of inclusion in the study. As regards
the rationalization of treatment on the basis of fever,
this study has confirmed that febrile illness was not
the basis for prescription of an anti-malarial per se.
Febrile, parasite-negative patients were still prescribed
an anti-malarial as much as afebrile patients with
RDT-negative results.
Laboratory confirmation of parasite infection is im-
portant to the management of malaria and other febrile
illness because to properly manage febrile illness, it is
necessary for clinicians to accurately know the actual in-
fection status of each patient. As RDTs may be the only
available tool for very remote areas in Zambia, the issue
of clinicians trusting the results is paramount if confirm-
ation of parasite infection has to remain the basis for
prescribing an anti-malarial.inst rapid diagnostic test results per district








Table 4 Distributions of fever, anti-malarial drugs given and rapid diagnostic test results by anti-malarial drug
prescription after laboratory results
District Total (%) Fever Prescribed anti-malarial drugs after laboratory results
Yes No
n (%) n (%)
Chibombo 637 (100) Yes 266 (90.8) 83 (24.1)
No 27 (9.2) 261 (75.9)
Total 293 (100) 344 (100)
Chingola 571 (100) Yes 394 (73.1) 15 (46.9)
No 145 (26.9) 17 (53.1)
Total 539 (100) 32 (100)
Chipata 345 (100) Yes 140 (41.1) 2 (50.0)
No 201 (58.9) 2 (50.0)
Total 341 (100) 4 (100)
Choma 408 (100) Yes 88 (27.1) 3 (3.6)
No 237 (72.9) 80 (96.4)
Total 325 (100) 83 (100)
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that provider non-compliance with test results can lead
to reductions in the ability of RDT introduction to re-
duce ACT consumption and concluded that this may
not be a major problem in Zambia [5], findings from the
eight health centres in the four districts has found a situ-
ation to the contrary. In terms of timing, the two studies
were conducted at the same time. Overall, over 70% of
children were treated for malaria after the availability of
RDT results. The treatments were ACT and other anti-
malarials but ACT was more prescribed compared to
other anti-malarials whether RDT results were positive
or not.
The high levels of malaria clinical diagnoses with anti-
malarial prescription in this study were observed across
all the districts despite the varied malaria prevalence. In
areas of high malaria transmission, where clinical diag-
nosis may be a marginally more effective predictor of
malaria infection, this practice would hardly raise con-
cern. The findings of this study do not allow for the fact
that the roll-out of RDTs may contribute to the changingTable 5 Factors independently associated with receiving
prescription
Factor AOR (95% CI)
RDT result
Positive 2.66 (2.00, 3.55)
Negative 1
Fever
Present 0.58 (0.52, 0.65)
Absent 1of malaria case definition to mean parasitological mal-
aria and not suspected malaria cases or fever cases.
The management of fever in children less than five
years in the districts where this study was conducted
may be interpreted to be non-compliant to RDT results
as there were less actual parasite-positive malaria pa-
tients than were treated. The report of Njama-Meya
et al. is reassuring in that the incidence of malaria in fe-
brile patients left untreated after seven days post a nega-
tive result was significantly lower than the incidence of
malaria in the whole cohort [18]. This finding supports
the policy of restricting anti-malarials to parasitologically
confirmed cases (as was also the findings of Msellem
et al., and others [19-25]).
The over-prescription pattern found in Chibombo and
the RDT compared to microscopy discrepancies reported
in Chipata (based on microscopy and RDT performance
as validated by other studies [9,26,27]) may indicate aFigure 1 Microscopic and rapid diagnostic test results and
prescription over time.
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tory technicians in Chibombo and Chipata, respectively.
It is important to underscore that over time in this
study, there was a decline in the number of positive mal-
aria cases and anti-malarial prescriptions, confirming the
already noted reduction in malaria prevalence country-
wide. Therefore, emphasizing the importance for RDT
result adherence to allow for interpretation of malaria
prevalence over time and treatment of actual malaria
cases. This would avoid presumptuous prescriptions and
thereby missing febrile cases that would require further
investigations and appropriate treatment.Conclusion
RDTs may contribute to treatment of febrile illness in
children under the age of five years for malaria and
non-malaria cases. However, compliance by the health
workers to test results at health facility level will still re-
quire further exploration, as their role is crucial in more
precise reporting of malaria cases in this era towards
the target of malaria elimination. The laboratory staff
at health facility level may still require in-service re-
orientation in microscopy where these facilities are avail-
able for correct interpretation on trends in malaria
epidemiology in Zambia.
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